Triamcinolone Acetonide

Controls severe or incapacitating allergic conditions. Sold as Triamcinolone Acetonide, Kenalog, Kenalog-10, Kenalog In Orabase, Kenalog-40 and 10 more. Every FDA application for this active ingredient: 18 branded and 127 generic.

As of Nov 15, 2026, FDA lists 145 applications for Triamcinolone Acetonide (sold as Triamcinolone Acetonide, Kenalog, Kenalog-10 and others), first approved Oct 23, 1958, with 8 new uses approved and 1 published complete response letter.

• First approved: Oct 23, 1958
• Applications: 145
• New uses approved: 8
• Complete response letters: 1
• Medicare spending, 2025: $169M